CAMBRIDGE, MA, UNITED STATES, May 18, 2026 /EINPresswire.com/ -- EyeCool Therapeutics today announced the publication ...
Immunotherapy could be a promising new treatment option for patients with difficult-to-treat depression. This is a key ...
Legacy Medical Consultants, a leading provider of allografts for the treatment of hard-to-heal chronic wounds, today announced the initiation of the REBOUND clinical trial: a prospective, post-market ...
The anti-inflammatory drug tocilizumab targets the IL-6 pathway to achieve a 54% remission rate in hard-to-treat depression.
ACTIVATE: A pilot randomized activity coaching trial to increase vitality and energy during post-operative pelvic radiation therapy for endometrial cancer. This is an ASCO Meeting Abstract from the ...
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic ...
Results of a multisite randomized trial of Bright IDEAS-Young Adults: Efficacy of problem-solving skills training on distress and health-related quality of life. This is an ASCO Meeting Abstract from ...
The study concluded that NEXGEL’s hydrogel patch significantly reduced laser plume generation and exposure during laser hair removal and the patch was associated with greater hair reduction and ...
Idiopathic normal-pressure hydrocephalus is a neurologic disorder characterized by impaired gait, balance, cognition, and bladder control in older adults. The disorder is treated with shunt surgery, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results